Browsing Tag
myelofibrosis
7 posts
Is mutant-selective JAK2 inhibition ready for clinical reality after Prelude Therapeutics’ FDA IND clearance?
Prelude Therapeutics gains FDA IND clearance for PRT12396. Read how mutant-selective JAK2 inhibition could reshape MPN drug development.
Myelofibrosis breakthrough? Incyte’s INCA033989 delivers clinical and molecular wins
Incyte’s mutCALR antibody shows promise in myelofibrosis and ET. Find out what ASH 2025 data reveals about INCA033989’s future potential.
Galecto pivots to oncology with Damora Therapeutics buyout and massive $285m funding boost
Discover how Galecto’s $285 M Damora Therapeutics acquisition and new mutCALR antibody pipeline could transform myelofibrosis and thrombocythemia treatment.
Novartis announces takeover bid for MorphoSys AG to boost oncology pipeline
In a significant move within the pharmaceutical industry, Novartis has entered into an agreement to launch a voluntary…
EC grants approval for GSK’s Omjjara for treatment of myelofibrosis patients with anaemia
In a landmark decision, the European Commission has approved GSK plc’s Omjjara (momelotinib), introducing a revolutionary treatment for…
GSK to acquire US biopharma company Sierra Oncology for $1.9bn
GlaxoSmithKline (GSK) has agreed to acquire Sierra Oncology, a California-based biopharma company, in a deal worth around $1.9…
Roche to acquire US biotech company Promedior for $1.4bn
Roche acquisition of Promedior : Swiss drugmaker Roche has agreed to acquire Massachusetts-based biotech company Promedior in a…